31. The branched-chain amino acids valine and leucine predict all-cause mortality in cardiovascular disease patients independently from the presence of type 2 diabetes mellitus. (December 2020) Authors: Muendlein, A.; Leiherer, A.; Saely, C.H.; Vonbank, A.; Schindewolf, M.; Dopheide, J.F.; Baumgartner, I.; Larcher, B.; Mader, A.; Fraunberger, P.; Drexel, H. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes. (August 2022) Authors: Leiherer, A.; Muendlein, A.; Saely, C.H.; Larcher, B.; Mader, A.; Maechler, M.; Sprenger, L.; Grabher, V.; Laaksonen, R.; Laaperi, M.; Jylha, A.; Fraunberger, P.; Drexel, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. The ceramide-based coronary event risk test (CERT) predicts cardiovascular mortality in cardiovascular disease patients with type 2 diabetes as well as in those without diabetes. (December 2020) Authors: Leiherer, A.; Muendlein, A.; Saely, C.H.; Laaksonen, R.; Laaperi, M.; Vonbank, A.; Larcher, B.; Mader, A.; Baumgartner, I.; Fraunberger, P.; Drexel, H. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. The creatinine to uromodulin ratio in serum predicts major cardiovascular events independently from the presence of type 2 diabetes. (August 2018) Authors: Leiherer, A.; Muendlein, A.; Saely, C.H.; Ebner, J.; Brandtner, E.M.; Mader, A.; Larcher, B.; Fraunberger, P.; Drexel, H. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. The Novel Adipokine C1Qtnf1 Significantly Predicts The Incidence Of Future Major Cardiovascular Events In Patients With Type 2 Diabetes. (August 2019) Authors: Muendlein, A.; Leiherer, A.; Saely, C.H.; Geiger, K.; Brandtner, E.M.; Larcher, B.; Mader, A.; Fraunberger, P.; Drexel, H. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. The Visceral Adiposity Index Predicts Cardiovascular Events Both In Cardiovascular Disease Patients With And In Those Without Diabetes. (August 2019) Authors: Saely, C.H.; Vonbank, A.; Heinzle, C.; Purin, D.; Larcher, B.; Mader, A.; Leiherer, A.; Muendlein, A.; Drexel, H. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Type 2 diabetes and different manifestations of pre-existing cardiovascular disease as predictors of specific cardiovascular events. (December 2020) Authors: Saely, C.H.; Vonbank, A.; Heinzle, C.F.; Zanolin-Purin, D.; Larcher, B.; Mader, A.; Sternbauer, S.; Schindewolf, M.; Baumgartner, I.; Leiherer, A.; Muendlein, A.; Drexel, H. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients. (August 2021) Authors: Sprenger, L.; Vonbank, A.; Larcher, B.; Mader, A.; Maechler, M.; Mutschlechner, B.; Klement, M.; Zanolin-Purin, D.; Leiherer, A.; Muendlein, A.; Drexel, H.; Saely, C.H. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Type 2 diabetes and risk of major cardiovascular events in peripheral artery disease versus coronary artery disease patients. (August 2022) Authors: Saely, C.H.; Vonbank, A.; Larcher, B.; Mader, A.; Maechler, M.; Sprenger, L.; Grabher, V.; Leiherer, A.; Muendlein, A.; Drexel, H. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Type 2 diabetes is a strong predictor for LDL cholesterol target achievement in patients with peripheral artery disease. (December 2020) Authors: Sternbauer, S.; Vonbank, A.; Heinzle, C.F.; Zanolin-Purin, D.; Dopheide, J.F.; Baumgartner, I.; Larcher, B.; Mader, A.; Leiherer, A.; Muendlein, A.; Drexel, H.; Saely, C.H. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗